- In May 2023, Miach Orthopaedics, Inc. has launched the Bridge Registry Post-Market Study for its Bridge-Enhanced ACL Restoration (BEAR®) Implant to treat ACL tears. This study will help the company gather real-world data on the implant's effectiveness, supporting its reputation as an innovator in ACL treatments and strengthening its market position
- In January 2023, Arthrex Inc. has received FDA clearance for its ACL TightRope implant for pediatric use, making it the first and only fixation device approved for ACL injuries in children. This approval enhances the company's position in the pediatric orthopedic market and opens new growth opportunities by expanding its product offerings for younger patients
